(Q39104662)

9 September 2017

title

Role of survivin in acute lung injury: epithelial cells of mice and humans (English)

1 reference

9 September 2017

1 reference

Yasuhiro Terasaki

1

1 reference

9 September 2017

Mika Terasaki

2

1 reference

9 September 2017

Hirokazu Urushiyama

3

1 reference

9 September 2017

Shinya Nagasaka

4

1 reference

9 September 2017

Mikiko Takahashi

5

1 reference

9 September 2017

Shinobu Kunugi

6

1 reference

9 September 2017

Arimi Ishikawa

7

1 reference

9 September 2017

Kyoko Wakamatsu

8

1 reference

9 September 2017

Naomi Kuwahara

9

1 reference

9 September 2017

Koichi Miyake

10

1 reference

9 September 2017

Yuh Fukuda

11

1 reference

9 September 2017

language of work or name

1 reference

26 August 2013

1 reference

9 September 2017

published in

Laboratory Investigation

1 reference

9 September 2017

volume

93

1 reference

9 September 2017

issue

10

1 reference

9 September 2017

page(s)

1147-1163

1 reference

Direct interaction between survivin and Smac/DIABLO is essential for the anti-apoptotic activity of survivin during taxol-induced apoptosis

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.103

Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.103

An IAP-IAP complex inhibits apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.103

HBXIP functions as a cofactor of survivin in apoptosis suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.103

Control of apoptosis and mitotic spindle checkpoint by survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.103

Survivin: a dual player in healthy and diseased skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.103

Survivin: role in normal cells and in pathological conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.103

Survivin and the inner centromere protein INCENP show similar cell-cycle localization and gene knockout phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.103

Role of the Survivin gene in pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.103

Survivin expression in the stomach: implications for mucosal integrity and protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.103

Expression of survivin during liver regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.103

Survivin-dependent angiogenesis in ischemic brain: molecular mechanisms of hypoxia-induced up-regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.103

The anti-apoptosis protein, survivin, mediates gastric epithelial cell cytoprotection against ethanol-induced injury via activation of the p34(cdc2) cyclin-dependent kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.103

Mitochondrial dynamics of survivin and "four dimensional" control of tumor cell apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.103

Down-regulation of survivin by antisense oligonucleotides increases apoptosis, inhibits cytokinesis and anchorage-independent growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.103

Deficiency of survivin in transgenic mice exacerbates Fas-induced apoptosis via mitochondrial pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.103

Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.103

Functions of type II pneumocyte-derived vascular endothelial growth factor in alveolar structure, acute inflammation, and vascular permeability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.103

Survivin, a cancer target with an emerging role in normal adult tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.103

Survivin expression in normal human bronchial epithelial cells: an early and critical step in tumorigenesis induced by tobacco exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.103

Expression of survivin after acute necrohemorrhagic pancreatitis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.103

Separating the anti-apoptotic and mitotic roles of survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.103

Nuclear survivin abrogates multiple cell cycle checkpoints and enhances viral oncolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.103

21 January 2018

IAPs: what's in a name?

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.103

Survivin splice variants regulate the balance between proliferation and cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.103

The role of survivin in the resistance of endometriotic stromal cells to drug-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.103

Protective role of the inhibitor of apoptosis protein, survivin, in toxin-induced acute renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.103

Survivin study: what is the next wave?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.103

A mutation found in the promoter region of the human survivin gene is correlated to overexpression of survivin in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.103

Drug-induced interstitial lung disease in tyrosine kinase inhibitor therapy for non-small cell lung cancer: a review on current insight

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.103

Regulation of mitochondrial Smac/DIABLO-selective release by survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.103

7 January 2021

Multiple immunoenzyme labeling using heat treatment combined with the polymer method: an analysis of the appropriate inactivation conditions of primary antibodies

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.103

7 January 2021

A novel anti-apoptosis gene: Re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.103

7 January 2021

Survivin: A novel player in insulin cardioprotection against myocardial ischemia/reperfusion injury

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.103

7 January 2021

Survivin regulates hematopoietic progenitor cell proliferation through p21WAF1/Cip1-dependent and -independent pathways

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.103

7 January 2021

10.1038/LABINVEST.2013.103

Identifiers

DOI

1 reference

Dimensions Publication ID

9 September 2017

1022619618

0 references

1 reference